DYN — DYNE THERAPEUTICS INC

Ownership history in Quantbot Technologies LP  ·  7 quarters on record

This page tracks every 13F SEC filing in which Quantbot Technologies LP reported a position in DYNE THERAPEUTICS INC (DYN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2025 Q3)
Avg. % of fund
0.0%
First filed
2021 Q3
Last filed
2025 Q3
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 17,513 +16,554 +1726.2% 0.01% $222K $12.65
2024 Q3 ADDED 959 +559 +139.8% 0.00% $34K $35.92
2022 Q4 REDUCED 400 -1,700 -81.0% 0.00% $5K $11.59
2022 Q2 REDUCED 2,100 -800 -27.6% 0.00% $14K $6.87
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    DYN price (monthly, adj. close)

Other funds also holding DYN

As of 2025 Q4 — sorted by position size

Atlas Venture Life Science Advisors, LLC 3Y 20.64% FCPM III SERVICES B.V. 14.01% Saturn V Capital Management LP 3Y 6.42% Palo Alto Investors LP 3Y 7Y 4.01% Vivo Capital, LLC 3Y 7Y 3.31% MPM BioImpact LLC 3Y 3.15% TCG Crossover Management, LLC 3Y 2.99% STEMPOINT CAPITAL LP 2.8% VR Adviser, LLC 3Y 2.1% Siren, L.L.C. 2.04%
← Back to Quantbot Technologies LP Holdings